PARSIPPANY, N.J., July 18, 2012 – PDI, Inc. (Nasdaq: PDII) today announced that the client related to a previously disclosed contract has received FDA approval to market its product. PDI had entered ...
PDI to receive $25.5 to $32.5 million up front cash payment and a contingent earnout payment Combination Would Create A Global Leader in Healthcare Commercial Services Parsippany, NJ & Yardley, PA, ...
PARSIPPANY, N.J., Oct. 30, 2012 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that it will release its third quarter 2012 financial results on Monday, November 5, 2012 after the market ...
Including loss of a penny per share from discontinued operations, net loss of PDI Inc. came in at 18 cents per share, wider than the year-ago loss of 6 cents. Total revenue of PDI Inc. grossed nearly ...
PARSIPPANY, N.J., Aug. 13, 2014 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII), a leading healthcare commercialization company, today announced that its Interpace Diagnostics subsidiary has entered the ...
Acquisitions position PDI as undisputed global leader with most robust software portfolio in enterprise and fuel supply chain software for the convenience retail, petroleum wholesale and logistics ...
PDI, Inc. (Nasdaq: PDII), a leading provider of integrated promotional outsource services to health care companies, today announced the expansion of its business with the acquisition of Group DCA, a ...
MONTREAL , Oct. 9 /CNW Telbec/ - In keeping with its consistent and strategic efforts to better serve their clientele and to facilitate the process of manufacturing and distributing printed material, ...
SADDLE RIVER, N.J.--(BUSINESS WIRE)--PDI, Inc. (NASDAQ: PDII), a pioneer in providing contract sales and commercial services to the biopharmaceutical industry, today announced the appointment of ...
PDI, Inc. has announced the signing of a collaboration agreement with a privately held molecular diagnostics company (the Company) to commercialize the Company’s molecular diagnostic tests. The ...
Welcome to the PDI second quarter financial results conference call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we will hold a Q&A session.
PARSIPPANY, N.J., Dec. 22, 2015 /PRNewswire/ -- PDI, Inc.(PDII) today reported that as the Company transitions to focusing solely on its molecular diagnostics operations, Nancy Lurker has resigned as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results